Saw Palmetto: What the Research Actually Says

If you have spent any time researching prostate health, you will almost certainly have come across saw palmetto.

It appears on the labels of countless supplements marketed at men over fifty. It is discussed in health forums, recommended in online articles, and sold in pharmacies across the UK. The claims made about it are often bold: that it shrinks the prostate, relieves urinary symptoms, and offers a natural alternative to medication.

But what does the research actually say?

The honest answer is more nuanced than most supplement labels suggest. There is real science behind saw palmetto, genuine debate among researchers, and a body of evidence that is neither as strong as its supporters claim nor as weak as its critics sometimes suggest.

This is an attempt to look at that evidence clearly, without the marketing, and give you the information you need to make a sensible decision.

What Is Saw Palmetto

Saw palmetto is a small palm tree native to the southeastern United States. Its scientific name is Serenoa repens. The berries of the plant have been used medicinally for centuries, originally by Native American communities who used them for urinary and reproductive health.

In modern supplementation, saw palmetto extract is made from the berries and is standardised to contain specific concentrations of fatty acids and plant sterols, the compounds believed to be responsible for its effects.

It is one of the most widely used herbal supplements in Europe and North America, particularly among men over fifty. In some European countries, it has been prescribed as a pharmaceutical treatment for benign prostatic hyperplasia, more commonly known as an enlarged prostate, which is the condition it is most frequently associated with.

Understanding what an enlarged prostate is and how it affects daily life is important context for evaluating whether saw palmetto might be relevant to you.

Why Men Over Fifty Are Looking for Answers

Benign prostatic hyperplasia is extraordinarily common. By the age of sixty, roughly half of all men have some degree of prostate enlargement. By the age of eighty, that figure rises to around ninety percent.

The symptoms it causes are not life-threatening, but they significantly affect quality of life. A frequent need to urinate, particularly at night. Difficulty starting urination. A weak or interrupted flow. A feeling that the bladder has not fully emptied. These are the kinds of symptoms that disrupt sleep, limit daily activities, and gradually erode confidence and comfort.

Conventional medical treatments exist and are effective. But they come with side effects that many men find difficult. Some medications can cause dizziness, reduced libido, and sexual dysfunction. Surgical options carry their own risks. It is entirely understandable that men looking at these options would want to know whether a gentler, natural alternative might offer some relief.

That is where saw palmetto enters the picture. And the question of whether it actually delivers on its promise is worth examining carefully.

What the Research Says

The research on saw palmetto is substantial. There have been dozens of clinical trials over the past three decades, which is more than most herbal supplements can claim. But the results have been inconsistent, and the interpretation of that evidence is genuinely contested.

The early studies

The early research on saw palmetto, conducted mainly in Europe during the 1980s and 1990s, was broadly positive. Multiple smaller trials found that saw palmetto extract reduced urinary symptoms associated with benign prostatic hyperplasia, improved urine flow, and was well tolerated with few side effects.

A significant review published in the Journal of the American Medical Association in 1998 analysed eighteen randomised trials involving nearly three thousand men and concluded that saw palmetto improved urinary symptoms and flow measures. This review was widely cited and contributed to saw palmetto's reputation as an effective natural treatment.

The larger trials

Later, larger and more rigorous trials produced more complicated results. The STEP trial, published in 2006, was a well-designed randomised controlled trial that compared saw palmetto to placebo in over two hundred men with moderate to severe urinary symptoms. It found no significant difference between the two groups across any of the measures tested.

A follow-up study published in 2011, which used higher doses of saw palmetto than previous trials, reached the same conclusion. Even at doses three times higher than those typically recommended, saw palmetto performed no better than placebo.

These larger trials caused genuine debate in the research community. Some researchers argued that they demonstrated saw palmetto simply did not work. Others pointed to differences in the patient populations, the duration of the trials, and the quality of the extracts used, arguing that earlier positive results should not be dismissed.

What the Evidence Looks Like in Summary

Study type	What it found	Weight of evidence
Early European trials	Positive effects on urinary symptoms and flow	Smaller, less rigorous designs
1998 JAMA review	Improved urinary symptoms across 18 trials	Influential but included older, smaller studies
STEP trial 2006	No significant benefit over placebo	Large, well-designed randomised trial
High-dose trial 2011	No benefit even at triple standard dose	Rigorous design, higher doses tested
Cochrane review 2023	Uncertain evidence, more research needed	Most comprehensive recent analysis

The most recent comprehensive analysis, published by the Cochrane Collaboration, concluded that the evidence for saw palmetto remains uncertain and that further high-quality research is needed before firm conclusions can be drawn.

That is not the same as saying it does not work. It is saying that the evidence is not yet strong enough to say definitively that it does.

How Saw Palmetto Is Thought to Work

The proposed mechanism of action for saw palmetto involves its effect on testosterone metabolism. The fatty acids and plant sterols in the extract are thought to inhibit an enzyme called 5-alpha reductase, which converts testosterone into dihydrotestosterone, a hormone that stimulates prostate cell growth.

This is actually the same mechanism targeted by finasteride, a commonly prescribed pharmaceutical medication for enlarged prostate. The difference is that finasteride's effect on this enzyme has been consistently demonstrated in clinical trials, while saw palmetto's effect on the same pathway in living human subjects has proved harder to replicate reliably.

There is also evidence that saw palmetto may have mild anti-inflammatory properties and may affect certain receptors involved in bladder function. These mechanisms could potentially explain some of the symptom relief reported in positive trials, even if the primary hormonal mechanism has been difficult to confirm.

Understanding how benign prostatic hyperplasia develops and progresses helps clarify why the mechanism matters when evaluating any treatment, conventional or natural.

Safety and Side Effects

One area where the evidence is consistently positive is safety. Saw palmetto is generally very well tolerated, and serious side effects are rare.

The most commonly reported side effects are mild digestive symptoms such as nausea and stomach discomfort, which tend to occur when the supplement is taken on an empty stomach. Taking it with food largely eliminates this issue for most people.

There have been rare case reports of more serious effects, including effects on bleeding time, which is relevant for anyone taking blood thinning medications. As with any supplement, it is worth discussing with your GP before starting, particularly if you are on prescribed medication.

One important point is that saw palmetto may affect PSA levels, a blood marker used to screen for prostate cancer. Some evidence suggests it can lower PSA readings, which could potentially mask a prostate cancer diagnosis if your doctor is not aware you are taking it. PSA testing is an important screening tool for prostate cancer, and your doctor should always know about any supplements you are taking before interpreting your results.

What This Means for Men Over Fifty in the UK

If you are experiencing urinary symptoms that might be related to prostate enlargement, the first step should always be a conversation with your GP.

This is important for two reasons. First, urinary symptoms have multiple possible causes, and not all of them are related to the prostate. Getting a proper assessment rules out conditions that require different treatment. Second, if the symptoms are related to prostate enlargement, your GP can discuss the full range of options, including lifestyle changes, medication, and monitoring, and help you decide what is appropriate for your situation.

Where does saw palmetto fit into this picture? The honest answer is that it sits in the category of supplements that may offer mild benefit for some people, have a reasonable safety profile, and carry relatively low risk if used sensibly alongside proper medical assessment rather than instead of it.

The quality of the extract matters

One factor that genuinely affects saw palmetto's potential effectiveness is the quality of the extract. Not all saw palmetto supplements are equivalent. The fatty acid content of the extract, which is the component most associated with its proposed mechanism of action, varies significantly between products.

Extracts standardised to contain at least 85 to 95 percent fatty acids are the form used in most of the positive clinical research. Many cheaper supplements on the market do not specify their fatty acid content or use whole berry powder rather than a standardised extract, which makes it very difficult to compare them to what was tested in clinical trials.

Dose and duration

The standard dose used in most research is 320 milligrams of standardised extract per day, either as a single dose or divided into two doses. Effects, if they occur, typically take several weeks to become noticeable. Trials that showed positive results generally ran for at least three to six months.

If you try saw palmetto and notice no difference after three months at the standard dose, the evidence suggests that continuing is unlikely to produce a different result.

Saw Palmetto and Hair Loss

Saw palmetto is also marketed for hair loss, specifically for androgenetic alopecia, the pattern of hair thinning linked to DHT that affects many men and some women as they age.

The logic is the same as for prostate health: if saw palmetto inhibits 5-alpha reductase and reduces DHT, it might slow DHT-related hair loss in the same way that finasteride does for hair loss treatment.

The evidence here is even more limited than for prostate symptoms. A small number of studies have shown modest positive effects, but the trials are generally small, short, and of lower quality. Androgenetic alopecia has well-established conventional treatments with much stronger evidence behind them. Saw palmetto may be worth considering as an adjunct, but it should not be seen as a substitute for treatments with a stronger evidence base.

The Honest Bottom Line

Saw palmetto is not a miracle supplement, and anyone selling it as one is overstating what the evidence supports.

It is also not worthless. The early research was not fabricated, and there are plausible biological mechanisms that could explain the symptom relief that some men report. The problem is that larger, more rigorous trials have been unable to reliably confirm those effects.

What this means in practice is that saw palmetto sits in a genuinely uncertain space. For some men, particularly those with mild to moderate urinary symptoms, it may offer some relief. For others, the benefit may be no more than placebo. There is currently no reliable way to predict which group any individual will fall into.

What can be said with confidence is that saw palmetto, taken at the standard dose of a quality standardised extract, is unlikely to cause harm. If you are considering it, do so alongside proper medical assessment of your symptoms, not instead of it. Tell your GP you are taking it, particularly before any PSA test. And give it a reasonable trial of at least three months before deciding whether it is making a difference.

The research is not yet settled. But that does not mean the conversation is over.

Make informed decisions. Work with your doctor. And do not let marketing tell you more than the evidence actually supports.